| Inaphaea Commercial update | 14-Oct-2025 | 07:00 | RNS |
| Half-year Report | 29-Sep-2025 | 07:00 | RNS |
| Inaphaea Commercial Update | 18-Sep-2025 | 07:00 | RNS |
| Cytolytix Commercial update | 01-Sep-2025 | 07:00 | RNS |
| Commercial update | 26-Aug-2025 | 07:00 | RNS |
| ValiRx Awarded Grant from Open University | 07-Aug-2025 | 10:51 | RNS |
| Update on Evaluation Agreement with Stingray Bio | 05-Aug-2025 | 09:53 | RNS |
| Licensing Agreement with Dominion Biotech Ltd | 04-Aug-2025 | 07:00 | RNS |
| Collaboration Agreement with Voxcell BioInnovation | 29-Jul-2025 | 07:00 | RNS |
| Result of AGM | 30-Jun-2025 | 15:48 | RNS |
| Ambrose Exercise Option on VAL401 | 20-Jun-2025 | 07:00 | RNS |
| ValiRx Investor Webinar | 09-Jun-2025 | 10:57 | RNS |
| Holding(s) in Company | 06-Jun-2025 | 10:54 | RNS |
| Final Results & Notice of AGM | 06-Jun-2025 | 07:00 | RNS |
| New Evaluation and Material Transfer Agreement | 03-Jun-2025 | 07:00 | RNS |
| Currency | UK Pounds |
| Share Price | 0.53p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 1.75p |
| 52 Week Low | 0.42p |
| Volume | 195,973 |
| Shares Issued | 374.35m |
| Market Cap | £1.97m |
| RiskGrade | 435 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 15:58 | 6,588 @ 0.53p |
| 15:37 | 1 @ 0.50p |
| 14:47 | 531 @ 0.50p |
| 13:38 | 70 @ 0.50p |
| 09:47 | 90 @ 0.50p |
You are here: research